Checked.be
Active
BE 0797.163.420Private limited company
PATCHACAP
Gisseleire Versélaan 64 ·1082 Sint-Agatha-Berchem, Belgium· 3 yrs active
Sector: Specialist medical practice
(86220)
Conclusion
PATCHACAP has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.13M and a net result of €425k. Equity is growing by ~54.5% per year across the filed fiscal years. Its solvency ranks better than 95% of 2224 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Based on the State Gazette, CBE and 3 annual accounts.
Key figures
| Equity | €1.13M |
| Net result | €425k |
| Better than sector | 95% |
| Active | 3 yrs |
Financial profile
94
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
100
Solvency
100
Growth
78
Stability
94
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
100
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€110k
estimate, not credit advice
Score history
61
2023
93
2024
100
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 26.46 (≥ 1.5)
+10
Quick ratio
Quick ratio 26.46 (≥ 1.0)
+5
Leverage
Debt/equity 0.03 (< 1.0)
+10
Profitability
ROE 38% (≥ 10%)
+10
Interest coverage
Interest coverage 3124.9× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 24-08-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Gross margin: growth of ~8.2%/year over 3 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 97.2% | 57.9% | |
| Net result | €425k | €59k | |
| Equity | €1.13M | €74k | |
| Gross operating margin | €628k | €95k | |
| Staff costs | €19k | €22k |
€609k
+21.9%
23-25
€425k
+23.9%
23-25
€471k
+20.9%
23-25
€1.16M
+22.4%
23-25
€1.13M
+60.3%
23-25
€821k
+133.5%
23-25
€19k
-4.2%
23-25
€138k
+25.2%
23-25
€32k
-86.8%
23-25
€32k
-86.8%
23-25
26.46
+985.5%
23-25
26.46
+985.5%
23-25
97.2%
+30.9%
23-25
0.03
-91.8%
23-25
37.6%
-22.7%
23-25
36.6%
+1.2%
23-25
3124.88
-79.1%
23-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema |
| Revenue | - | - | - |
| EBITDA | €609k | €500k | €524k |
| Net profit | €425k | €343k | €361k |
| Cash flow | €471k | €390k | €408k |
| Staff costs | €19k | €19k | €14k |
| Income taxes | €138k | €111k | €116k |
| Dividends | - | - | - |
| Total assets | €1.16M | €950k | €819k |
| Equity | €1.13M | €705k | €362k |
| Debt | €32k | €245k | €457k |
| of which ≤ 1y | €32k | €245k | €457k |
| of which > 1y | - | - | - |
| Working capital | €821k | €352k | €-38k |
| Employees (FTE) | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | 26.46 | 2.44 | 0.92 |
| Quick ratio | 26.46 | 2.44 | 0.92 |
| Working capital ratio | 70.6% | 37.0% | -4.6% |
| Solvency | 97.2% | 74.3% | 44.2% |
| Debt / equity | 0.03 | 0.35 | 1.26 |
| Long-term debt ratio | - | - | - |
| Interest coverage | 3124.88 | 14940.20 | 17649.63 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | 36.6% | 36.1% | 44.1% |
| ROE | 37.6% | 48.7% | 99.7% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Balance-sheet composition 2025
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €1.16M | €950k | €819k |
| Fixed assets | 21/28 | €310k | €354k | €400k |
| Intangible fixed assets | 21 | €306k | €349k | €393k |
| Tangible fixed assets | 22/27 | €5k | €5k | €7k |
| Current assets | 29/58 | €853k | €596k | €419k |
| Amounts receivable within one year | 40/41 | €14k | - | €7k |
| Investments | 50/53 | €470k | €290k | €50k |
| Cash & bank | 54/58 | €149k | €140k | €197k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.16M | €950k | €819k |
| Equity | 10/15 | €1.13M | €705k | €362k |
| Contributions / capital | 10/11 | €1k | €1k | €1k |
| Accumulated profits (losses) | 14 | €1.13M | €704k | €361k |
| Amounts payable | 17/49 | €32k | €245k | €457k |
| Amounts payable within one year | 42/48 | €32k | €245k | €457k |
| Trade debts payable within one year | 44 | - | - | €891 |
| Income statement | ||||
| Gross operating margin | 9900 | €628k | €521k | €540k |
| Operating result | 9901 | €564k | €454k | €477k |
| Financial charges | 65 | €195 | €33 | €30 |
| Result before taxes | 9903 | €564k | €454k | €476k |
| Income taxes | 67/77 | €138k | €111k | €116k |
| Net result for the period | 9904 | €425k | €343k | €361k |
| Result to be appropriated | 9905 | €425k | €343k | €361k |
Legal Structure
| NACE primary | Specialist medical practice(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 13-01-2023 |
| Status | Active |
| Postal code | 1082 |
Establishment units
PATCHACAP
since 20232.340.325.235
Real-estate footprint
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21342B0073/00X014 | Brussels | 345 m² | 1 · 93 m² | 14.8 m · 4 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 24 days late
2025
31-12
Financial
Highest result since 2023net €425k ▲23.9%
Operating result €564k, net result €425k, both a record.
31-12
Financial
Liquidity times 11current ratio 26.46
Current ratio from 2.44 to 26.46; short-term debt falls from €245k to €32k.
31-12
Financial
Equity above €1MEq €1.13M ▲60.3%
3 profitable years in a row build equity to €1.13M.
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €343k ▼4.9%
Net result drops to €343k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity triplescurrent ratio 2.44
Current ratio from 0.92 to 2.44; short-term debt falls from €457k to €245k.
31-12
Financial
Equity above €500kEq €705k ▲94.9%
2 profitable years in a row build equity to €705k.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Specialist medical practice86220
Names & trade names
| Legal nameFR | PATCHACAP |
Similar companies
Dr. Koen Vindevoghel
BE 0818.372.865 · Dentergem
DOKTER SMET BFT
BE 0607.844.758 · Harelbeke
Vert
BE 0719.285.286 · Kortrijk
DE VARÉ - TREMMERY
BE 0882.549.253 · Gent
DOKTER REINOUD CARTUYVELS
BE 0473.303.580 · Heusden-Zolder